سعر توبرا اليكس Tobra-alex‏ 80مجم/2مل امبول 2026

Tobramycin 80 mg/2 ml ampoule for IV/IM use (Alexandria Co. for Pharmaceuticals), aminoglycoside antibiotic.

• Eighth-nerve toxicity (dizziness, vertigo, tinnitus, hearing loss), nephrotoxicity (rising BUN/creatinine, oliguria, proteinuria), anaemia, granulocytopenia, thrombocytopenia, rash, nausea, vomiting, injection-site pain, electrolyte decreases.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any aminoglycoside.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: potential for ototoxicity (auditory and vestibular, often irreversible), nephrotoxicity and neurotoxicity; keep patients under close clinical observation, especially with renal impairment, high doses or prolonged therapy.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Avoid concurrent/sequential use of other neurotoxic or nephrotoxic drugs and potent diuretics (ethacrynic acid, furosemide). Contains sodium metabisulfite (sulfite allergy risk) in the US product.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Potent diuretics (ethacrynic acid, furosemide)Should not be given concurrently; diuretics may enhance aminoglycoside ototoxicity.DailyMed (U.S. National Library of Medicine)
• Neuromuscular blocking agents (e.g. succinylcholine)Possibility of prolonged or secondary apnoea in anaesthetised patients.DailyMed (U.S. National Library of Medicine)

• Aminoglycosides can cause fetal harm; they cross the placenta (irreversible congenital deafness reported with streptomycin). Patients should be apprised of the hazard.International label, same formulation · DailyMed (U.S. National Library of Medicine)